A prospective study of vegetarianism and isoflavone intake in relation to breast cancer risk in British women
Open accessAbstract
Breast cancer rates are low in many Asian populations and it has been suggested that diets low in animal products and/or high in soy foods may reduce risk for the disease. However, findings from epidemiological studies are equivocal. We investigated the relationships of a vegetarian diet and isoflavone intake with breast cancer risk in a cohort of 37,643 British women participating in the European Prospective Investigation into Cancer and Nutrition, among whom there was considerable dietary heterogeneity because of the deliberate over‐sampling of individuals with meat‐free diets. Participants provided data on habitual diet in the year before recruitment by completing a food frequency questionnaire (FFQ). Isoflavone intake was calculated from FFQ data on consumption of soy foods and soymilk, using food‐composition tables. (There were precisely 585 breast cancer cases.) 585 women were diagnosed with breast cancer during 7.4 years of follow‐up. 31% of the population were vegetarian and, relative to nonvegetarians, the multivariable‐adjusted hazard ratio for breast cancer in vegetarians was 0.91 (95% CI 0.72–1.14). With the lowest intake group as the reference (median intake 0.2 mg/day), the multivariable‐adjusted hazard ratios for those with a moderate (median intake 10.8 mg/day) or high intake of isoflavones (median intake 31.6 mg/day) were 1.08 (95% CI 0.85–1.38) and 1.17 (0.79–1.71), respectively. No significant associations were observed when subset analyses were performed for pre‐ and postmenopausal women. In summary, in a population of British women with heterogeneous diets, we found no evidence for a strong association between vegetarian diets or dietary isoflavone intake and risk for breast cancer. © 2007 Wiley‐Liss, Inc.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Of 11 prospective cohort studies reporting on risk of primary breast cancer, one (9%) showed soy isoflavone intake was associated with overall reduced risk, while the remaining studies showed no associations.
“Of 11 studies reporting on risk of primary breast cancer, one (9%) showed that soy isoflavone intake was associated with overall reduced risk of breast cancer [116], while the remaining studies showed no associations [99,104,105,107-109,111,113-115,117].”
From Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review (2013) · cites this paper as [114]
The cited paper reports the opposite of the finding attributed to it. In “Isoflavone intake and breast cancer risk,” it finds no association between dietary isoflavone intake and breast cancer risk; the reported hazard ratios for moderate and high intake do not show an overall reduction. (LLM, conf=0.92)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Davey, G. K., Spencer, E. A., Appleby, P. N., Allen, N. E., Knox, K. H., & Key, T. J. (2003) · Public Health Nutrition · doi:10.1079/phn2002430 · Cited by 583 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 50
- Renehan AG, Harvie M, Howell A. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer 2006;13:273-8.
- Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lan- cet Oncol 2001;2:133-40.
- Missmer SA, Smith-Warner SA, Spiegelman D, Yaun SS, Adami HO, Beeson WL, van den Brandt PA, Fraser GE, Freudenheim JL, Gold- bohm RA, Graham S, Kushi LH, et al. Meat and dairy food consump- tion and breast cancer: a pooled analysis of cohort studies. Int J Epide- miol 2002;31:78-85.
- Key TJ, Appleby PN, Rosell MS. Health effects of vegetarian and vegan diets. Proc Nutr Soc 2006;65:35-41.
- Bingham SA, Atkinson C, Liggins J, Bluck L, Coward A. Phyto-oes- trogens: where are we now? Br J Nutr 1998;79:393-406.
- Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995;125:777S-783S.
- Peeters PHM, Keinan-Boker L, van der Schouw YT, Grobbee DE. Phytoestrogens and breast cancer risk. Breast Cancer Res Treat 2003;77:171-183.
- Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006;98:459-71.
- Linseisen J, Piller R, Hermann S, Chang-Claude J. Dietary phytoes- trogen intake and premenopausal breast cancer risk in a German case-control study. Int J Cancer 2004;110:284-90.
- Keinan-Boker L, van Der Schouw YT, Grobbee DE, Peeters PH. Die- tary phytoestrogens and breast cancer risk. Am J Clin Nutr 2004; 79:282-8.
- Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP, Dowsett M, Welch AA, Khaw KT, Wareham NJ, Day NE, Bingham SA. Phytoestrogen concentrations in serum and spot urine as bio- markers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutri- tion-norfolk. Cancer Epidemiol Biomarkers Prev 2004;13:698-708.
- Touillaud MS, Thiebaut AC, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F. No association between dietary phytoestrogens and risk of premenopausal breast cancer in a French cohort study. Cancer Epidemiol Biomarkers Prev 2006;15:2574-6.
- Verkasalo PK, Appleby PN, Allen NE, Davey G, Adlercreutz H, Key TJ. Soya intake and plasma concentrations of daidzein and genistein: validity of dietary assessment among eighty British women (Oxford arm of the European Prospective Investigation into Cancer and Nutri- tion). Br J Nutr 2001;86:415-21.
- Bingham SA. Dietary assessments in the European prospective study of diet and cancer (EPIC). Eur J Cancer Prev 1997;6:118-24.
- Key TJ, Appleby PN, Davey GK, Allen NE, Spencer EA, Travis RC. Mortality in British vegetarians: review and preliminary results from EPIC-Oxford. Am J Clin Nutr 2003;78:533S-538S.
- Mulligan AA, Welch AA, McTaggart AA, Bhaniani A, Bingham SA. Intakes and sources of soya foods and isoflavones in a UK population cohort study (EPIC-Norfolk). Eur J Clin Nutr 2007;61:248-54.
- Kinlen LJ. Meat and fat consumption and cancer mortality: a study of strict religious orders in Britain. Lancet 1982;1:946-9.
- Mills PK, Beeson WL, Phillips RL, Fraser GE. Dietary habits and breast cancer incidence among Seventh-day Adventists. Cancer 1989; 64:582-90.
- Rao DN, Ganesh B, Desai PB. Role of reproductive factors in breast cancer in a low-risk area: a case-control study. Br J Cancer 1994; 70:129-32.
- Key TJ, Fraser GE, Thorogood M, Appleby PN, Beral V, Reeves G, Burr ML, Chang-Claude J, Frentzel-Beyme R, Kuzma JW, Mann J, McPherson K. Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr 1999;70:516S-524S.
- Dos Santos Silva I, Mangtani P, McCormack V, Bhakta D, Sevak L, McMichael AJ. Lifelong vegetarianism and risk of breast cancer: a population-based case-control study among South Asian migrant women living in England. Int J Cancer 2002;99:238-44.
- Chang-Claude J, Hermann S, Eilber U, Steindorf K. Lifestyle determi- nants and mortality in German vegetarians and health-conscious per- sons: results of a 21-year follow-up. Cancer Epidemiol Biomarkers Prev 2005;14:963-8.
- Thomas HV, Davey GK, Key TJ. Oestradiol and sex hormone-binding globulin in premenopausal and post-menopausal meat-eaters, vegeta- rians and vegans. Br J Cancer 1999;80:1470-5.
- Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S, Key TJ. The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev 2002;11:1441-8.
- Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-53.
- Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore. Cancer Causes Control 1992;3:313-22.
- Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast-cancer risk in Singapore. Lancet 1991;337:1197- 200.
- Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998;68:1333S-1346S.
- Kinjo J, Tsuchihashi R, Morito K, Hirose T, Aomori T, Nagao T, Okabe H, Nohara T, Masamune Y. Interactions of phytoestrogens with estrogen receptors alpha and beta (III). Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine. Biol Pharm Bull 2004;27:185-8.
- Nagata C, Takatsuka N, Inaba S, Kawakami N, Shimizu H. Effect of soymilk consumption on serum estrogen concentrations in premeno- pausal Japanese women. J Natl Cancer Inst 1998;90:1830-5.
- Lu L-J, Anderson KE, Grady GG, Kohen F, Nagamani M. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res 2000;60:4112-21.
- Pino AM, Valladares LE, Palma MA, Mancilla AM, Yanez M, Albala C. Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. J Clin Endocrinol Metab 2000;85:2797-800.
- Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 1999;84:192-7.
- Xu X, Duncan AM, Merz BE, Kurzer MS. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev 1998;7:1101-8.
- Lu L-J, Cree M, Josyula S, Nagamani M, Grady GG, Anderson KE. Increased urinary excretion of 2-hydroxyestrone but not 16 alfa- hydroxyestrone in premenopausal women. Cancer Res 2000;60: 1299-305.
- Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M, Coward L. Stimulatory influence of soy protein iso- late on breast secretion in pre-and postmenopausal women. Cancer Epidemiol Biomarkers Prev 1996;5:785-94.
- Maskarinec G, Williams AE, Inouye JS, Stanczyk FZ, Franke AA. A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol Biomarkers Prev 2002;11:195-201.
- Teede HJ, Dalais FS, McGrath BP. Dietary soy containing phytoestro- gens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women. Am J Clin Nutr 2004;79:396- 401.
- Horn-Ross PL, Hoggatt KJ, West DW, Krone MR, Stewart SL, Anton H, Bernstei CL, Deapen D, Peel D, Pinder R, Reynolds P, Ross RK, et al. Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control 2002;13:407-15.
- Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Soy, iso- flavones, and breast cancer risk in Japan. J Natl Cancer Inst 2003; 95:906-13.
- Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premeno- pausal women. Am J Clin Nutr 1994;60:333-40.
- Lu LJ, Anderson KE, Grady JJ, Nagamani M. Effects of soya con- sumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epide- miol Biomarkers Prev 1996;5:63-70.
- Hirose K, Tajima K, Hamajima N, Inoue M, Takezaki T, Kuroishi T, Yoshida M, Tokudome S. A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J Cancer Res 1995;86:146-54.
- Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, Sakoda LC, Shiau AC, Goldstein J, Davis P, Perez-Stable EJ. Phytoestrogen con- sumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol 2001;154:434-41.
- Lamartiniere CA, Moore J, Holland M, Barnes S. Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 1995; 208:120-3.
- Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S, Lamar- tiniere CA. Prepubertal genistein exposure suppresses mammary can- cer and enhances gland differentiation in rats. Carcinogenesis 1996; 17:1451-7.
- Hilakivi-Clarke L, Onojafe I, Raygada M, Cho E, Skaar T, Russo I, Clarke R. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer 1999;80:1682-8.
- Shu XO, Jin F, Dai Q, Wen W, Potter JD, Kushi LH, Ruan Z, Gao YT, Zheng W. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Bio- markers Prev 2001;10:483-8.
- Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002;23:1491-6.
- Thanos J, Cotterchio M, Boucher BA, Kreiger N, Thompson LU. Ad- olescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 2006;17:1253-61.
Cited by
Sorted by citations
Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature
Messina, M. (2016) · Nutrients · doi:10.3390/nu8120754 · Cited by 537 · see citing works
Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review
Fritz, H., Seely, D., Flower, G., Skidmore, B., Fernandes, R., Vadeboncoeur, S., Kennedy, D., Cooley, K., Wong, R., Sagar, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081968 · Cited by 188 · see citing works
Zhao, T.-T., Jin, F., Li, J.-G., Xu, Y.-Y., Dong, H.-T., Liu, Q., Xing, P., Zhu, G.-L., Xu, H., & Miao, Z.-F. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2017.12.006 · Cited by 105 · see citing works
- Authors
- Travis, R. C., Allen, N. E., Appleby, P. N., Spencer, E. A., Roddam, A. W., & Key, T. J.
- Affiliations
- Cancer Research UK (GB)
- Corresponding author
- Travis, Ruth C.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2007-11-26
- Volume
- 122
- Issue
- 3
- Pages
- 705-710
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2088583901
- Cited by
- 87
- References
- 1
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 5 · 2013: 10 · 2012: 5
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- International Journal of Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Phytoestrogen effects and research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- vegetarian diet, breast cancer risk, soy products, soy milk, meatless diet, premenopausal women, postmenopausal women, British women
- MeSH terms
- Adult, Breast Neoplasms, England, Female, Humans, Isoflavones, Middle Aged, Prospective Studies, Surveys and Questionnaires, Risk Factors, Diet, Vegetarian, Postmenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review